Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $101.78 USD
Change Today -0.13 / -0.13%
Volume 5.5M
As of 1:26 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gregg H. Alton

Executive Vice President of Corporate & Medical Affairs and Secretary,Gilead Sciences Inc.
AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Gregg H. Alton serves as an Executive Vice President of Corporate and Medical Affairs at Gilead Sciences Inc. and Gilead Palo Alto, Inc. Mr. Alton served as Senior Vice President of Gilead Sciences Inc. from July 2005 to August 3, 2009 and also served as its General Counsel since 2000. He served as Vice President at Gilead Sciences Inc. from 2001 to July 2005 and served as its Associate General Counsel from 1999 to 2001. From 2000 to 2009, Mr. Alton served various ...

Read Full Background

Corporate Headquarters*

333 Lakeside Drive
Foster City, California 94404

United States

Phone: 650-574-3000
Fax: 650-578-9264

Board Members Memberships*

Non-Employee Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee


University of California Berkeley
Stanford University Law school

Other Affiliations*

Annual Compensation*

Total Annual Compensation$814,300

Stock Options*

Restricted Stock Awards$2,474,166
All Other Compensation$8,702
Exercised Options572,000
Exercised Options Value$36,592,219
Exercisable Options434,173
Exercisable Options Value$29,610,848
Unexercisable Options195,579
Unexercisable Options Value$9,812,025
Total Value of Options$76,015,091
Total Number of Options1,201,752

Total Compensation*

Total Annual Cash Compensation$1,805,802
Total Short Term Compensation$814,300
Other Long Term Compensation$2,482,868
Total Calculated Compensation$5,977,304
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GILD:US $101.71 USD -0.20


Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Allergan plc
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
Olivier Brandicourt Chief Executive Officer and Director
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GILEAD SCIENCES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at